Trial · NCT07900048
Development and Evaluation of a Digital Game Intervention Targeting Children Vulnerable to ADHD
NCT07900048, Not applicable, Not yet recruiting, The Hong Kong Polytechnic University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Development and Evaluation of a Digital Game Intervention Targeting Children Vulnerable to ADHD. Trials, record NCT07900048. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07900048
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Development and Evaluation of a Digital Game Intervention Targeting Children Vulnerable to ADHD
- NCT number
- NCT07900048
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 100 participants, estimated
- Lead sponsor
- The Hong Kong Polytechnic University
- Conditions
- ADHD or ADHD Traits
- Interventions
- Digital Game Intervention, Tetris
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Visual Continuous Performance Task (CPT) | Baseline (Week 0), Week 8 (Test-1), Week 16 (Test-2) | Sustained attention measured by the Visual Continuous Performance Task. The outcome is the longest interval between errors in seconds. A longer interval indicates better sustained attention. This task is not a scale and has no fixed minimum or maximum. |
| Primary | Memory recognition task | Baseline (Week 0), Week 8 (Test-1), Week 16 (Test-2) | Memory ability measured by a word recognition task. Participants memorize 20 words and then recognize them among 40 words. The outcome is the percentage of correct recognition. The range is 0 to 100. A higher percentage indicates better memory. |
| Primary | London Tower task | Baseline (Week 0), Week 8 (Test-1), Week 16 (Test-2) | Planning ability measured by the Tower of London task. The outcome is the number of moves needed to reach the target configuration. Fewer moves indicate better planning. The minimum depends on the item and there is no fixed maximum. |
| Primary | Swanson, Nolan, and Pelham Rating Scale, Fourth Edition (SNAP-IV), Parent Form | Baseline (Week 0), Week 8 (Test-1), Week 16 (Test-2) | Parent rated ADHD symptoms measured by the Swanson Nolan and Pelham Rating Scale Fourth Edition Parent Form. The Inattention and Hyperactivity and Impulsivity subscales each have 9 items rated from 0 Never to 3 Very often. The subscale mean score range is 0 to 3. Higher scores indicate worse ADHD symptoms. If total subscale scores are reported the range is 0 to 27 for each subscale and 0 to 54 for the full scale. Higher scores indicate worse ADHD symptoms. |
| Primary | Conners' Abbreviated Symptom Questionnaire (C-ASQ), Teacher Form | Baseline (Week 0), Week 8 (Test-1), Week 16 (Test-2) | Teacher rated ADHD symptoms measured by the Conners Abbreviated Symptom Questionnaire Teacher Form. The questionnaire has 10 items rated from 0 Never to 3 Very often. The total score range is 0 to 30. Higher scores indicate worse ADHD symptoms. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Continuous Performance Test | Primary outcome | ConductCognition |
| Tower Planning | Primary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07900048
GET https://conductscience.org/api/trials/v1/NCT07900048/registered